Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment
Introduction: Antipsychotics agents increase morbidity and mortality due to their metabolic impact. Information on its prescription and follow-up is scarce. The objective of this study was to estimate the chronic antipsychotic prescription prevalence and to evaluate the metabolic monitoring of patie...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/32653 |
| Aporte de: |
| id |
I10-R10article-32653 |
|---|---|
| record_format |
ojs |
| institution |
Universidad Nacional de Córdoba |
| institution_str |
I-10 |
| repository_str |
R-10 |
| container_title_str |
Revistas de la UNC |
| language |
Español |
| format |
Artículo revista |
| topic |
antipsychotic agents prevalence aged monitoring antipsicóticos prevalencia ancianos monitoreo antipsicóticos prevalência idosos monitoramento |
| spellingShingle |
antipsychotic agents prevalence aged monitoring antipsicóticos prevalencia ancianos monitoreo antipsicóticos prevalência idosos monitoramento Vivacqua, María Noelia Abudarham, Tomás Pagotto, Vanina Faccioli, José Luis Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| topic_facet |
antipsychotic agents prevalence aged monitoring antipsicóticos prevalencia ancianos monitoreo antipsicóticos prevalência idosos monitoramento |
| author |
Vivacqua, María Noelia Abudarham, Tomás Pagotto, Vanina Faccioli, José Luis |
| author_facet |
Vivacqua, María Noelia Abudarham, Tomás Pagotto, Vanina Faccioli, José Luis |
| author_sort |
Vivacqua, María Noelia |
| title |
Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| title_short |
Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| title_full |
Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| title_fullStr |
Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| title_full_unstemmed |
Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| title_sort |
antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment |
| description |
Introduction: Antipsychotics agents increase morbidity and mortality due to their metabolic impact. Information on its prescription and follow-up is scarce. The objective of this study was to estimate the chronic antipsychotic prescription prevalence and to evaluate the metabolic monitoring of patients treated with these medications.
Methods: We examined a retrospective cohort of patients older than 18 years treated in the outpatient setting of a hospital in Argentina. The crude and adjusted prevalence of chronic antipsychotic prescription was estimated by indirect standardization of the World Health Organization population, with its confidence interval (95%). It was evaluated whether the patients had biochemical determinations, systolic blood pressure (SBP), and body mass index (BMI) at the beginning and at 12 months of their treatment.
Results: The crude antipsychotic prescription prevalence was 23.8 ‰ (95% CI 23.0 - 24.6) and the adjusted prevalence was 10.1 ‰ (95% CI 9.5-10.7). 3702 patients were evaluated. The male:female ratio was 0.6. Median age 77.5 years (IQR 25-75: 59.5-86.1). Quetiapine was the most frequently prescribed. Initial determinations: Lipid profile 1804 (48.7%), blood glucose 2034 (54.9%), SBP 2546 (68.8%) and BMI 1584 (42.8%). At 12 months: Lipid profile 680 (18.4%), blood glucose 898 (24.3%), SAT 1609 (43.5%), and BMI 1584 (21.7%).
Conclusions: We observed a higher prevalence of atypical antipsychotic prescription in the elderly and female population and scarce registry of biochemical determinations for adverse effects follow-up.
|
| publisher |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
| publishDate |
2021 |
| url |
https://revistas.unc.edu.ar/index.php/med/article/view/32653 |
| work_keys_str_mv |
AT vivacquamarianoelia antipsychoticprescriptionprevalenceandmetabolicmonitoringofpatientsunderchronictreatment AT abudarhamtomas antipsychoticprescriptionprevalenceandmetabolicmonitoringofpatientsunderchronictreatment AT pagottovanina antipsychoticprescriptionprevalenceandmetabolicmonitoringofpatientsunderchronictreatment AT facciolijoseluis antipsychoticprescriptionprevalenceandmetabolicmonitoringofpatientsunderchronictreatment AT vivacquamarianoelia prevalenciaenlaprescripciondeantipsicoticosymonitoreometabolicoenpacientesbajotratamientocronico AT abudarhamtomas prevalenciaenlaprescripciondeantipsicoticosymonitoreometabolicoenpacientesbajotratamientocronico AT pagottovanina prevalenciaenlaprescripciondeantipsicoticosymonitoreometabolicoenpacientesbajotratamientocronico AT facciolijoseluis prevalenciaenlaprescripciondeantipsicoticosymonitoreometabolicoenpacientesbajotratamientocronico AT vivacquamarianoelia prevalencianaprescricaodeantipsicoticosemonitoramentometabolicoempacientesemtratamentocronico AT abudarhamtomas prevalencianaprescricaodeantipsicoticosemonitoramentometabolicoempacientesemtratamentocronico AT pagottovanina prevalencianaprescricaodeantipsicoticosemonitoramentometabolicoempacientesemtratamentocronico AT facciolijoseluis prevalencianaprescricaodeantipsicoticosemonitoramentometabolicoempacientesemtratamentocronico |
| bdutipo_str |
Revistas |
| _version_ |
1764819784444149764 |